Tailoring Antiplatelet Therapy Intensity to Ischemic and Bleeding Risk.
Baber U, Leisman DE, Cohen DJ, Gibson CM, Henry TD, Dangas G, Moliterno D, Kini A, Krucoff M, Colombo A, Chieffo A, Sartori S, Witzenbichler B, Steg PG, Pocock SJ, Mehran R.
Baber U, et al. Among authors: gibson cm.
Circ Cardiovasc Qual Outcomes. 2019 Jan;12(1):e004945. doi: 10.1161/CIRCOUTCOMES.118.004945.
Circ Cardiovasc Qual Outcomes. 2019.
PMID: 30606052